Switch to:

Castle Biosciences EV-to-Revenue

: 13.68 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Castle Biosciences's enterprise value is $855.47 Mil. Castle Biosciences's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $62.54 Mil. Therefore, Castle Biosciences's EV-to-Revenue for today is 13.68.

NAS:CSTL' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.1   Med: 8.5   Max: 12.9
Current: 13.68

4.1
12.9

During the past 3 years, the highest EV-to-Revenue of Castle Biosciences was 12.90. The lowest was 4.10. And the median was 8.50.

NAS:CSTL's EV-to-Revenue is ranked lower than
66% of the 219 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 7.55 vs. NAS:CSTL: 13.68 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-10-22), Castle Biosciences's stock price is $51.34. Castle Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $3.72. Therefore, Castle Biosciences's PS Ratio for today is 13.81.


Castle Biosciences EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
EV-to-Revenue 0.00 0.00 9.93

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.24 9.93 8.01 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Castle Biosciences EV-to-Revenue Distribution

* The bar in red indicates where Castle Biosciences's EV-to-Revenue falls into.



Castle Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Castle Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=855.472/62.543
=13.68

Castle Biosciences's current Enterprise Value is $855.47 Mil.
Castle Biosciences's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 14.775 (Sep. 2019 ) + 17.635 (Dec. 2019 ) + 17.418 (Mar. 2020 ) + 12.715 (Jun. 2020 ) = $62.54 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences  (NAS:CSTL) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Castle Biosciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=51.34/3.717
=13.81

Castle Biosciences's share price for today is $51.34.
Castle Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 1.033 (Sep. 2019 ) + 1.029 (Dec. 2019 ) + 0.93 (Mar. 2020 ) + 0.725 (Jun. 2020 ) = $3.72.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences EV-to-Revenue Related Terms


Castle Biosciences EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)